Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives

Int J Biol Sci. 2020 Jul 19;16(14):2518-2526. doi: 10.7150/ijbs.48330. eCollection 2020.

Abstract

IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and renal failure. The exact pathogenesis of IgAN is not well defined, but some genetic studies have led to a novel discovery that the immunoproteasome probably plays an important role in IgAN. The immunoproteasome is a proteasome variant that is expressed when cells are stressed or receive inflammatory signals. While immunoproteasome is suggested to be mainly involved in major histocompatibility complex-I (MHC-I) antigen presentation, recent studies indicate that it may assert broad functions in trafficking events that activate both innate and adaptive immunity. In this review, we first summarize new insights into its functions in immunity, and discuss how it underlies its associations with IgAN. We also highlight its potential as a therapeutic target for the future.

Keywords: Autoimmunity; Glomerulonephritis; IgA nephropathy; Immunoproteasome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antigen Presentation
  • B-Lymphocytes / physiology
  • Cytokines / metabolism
  • Glomerulonephritis, IGA / etiology*
  • Glomerulonephritis, IGA / metabolism
  • Glomerulonephritis, IGA / therapy
  • Humans
  • Molecular Targeted Therapy
  • Proteasome Endopeptidase Complex / immunology*
  • T-Lymphocytes / physiology

Substances

  • Cytokines
  • Proteasome Endopeptidase Complex